Luis Ferreira Moita: Rethinking Sepsis Care Through the Lancet Commission Initiative
Luis Ferreira Moita, Executive Director of Medicine ULisboa for Health Clinical Research and Innovation (MUHCRI) and Associate Professor at the Faculty of Medicine University of Lisbon, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in The Lancet:
“The Lancet is launching a new commission on sepsis, in which I am honored to participate.
The Lancet Commission on Sepsis is a multidisciplinary initiative established to address the stagnation in global sepsis outcomes.
Sepsis remains a leading cause of death characterized by ‘life-threatening organ dysfunction‘.
Current challenges include a discrepancy in global incidence data, a lack of validated bedside diagnostics, and an outdated immunopathology model that fails to account for complex biological pathways.
Furthermore, the long-term health needs of sepsis survivors remain critically understudied.
The Commission aims to transform care by:
- Systematically appraising sepsis epidemiology and survivorship,
- Redesigning systems to move care beyond the intensive care unit,
- Formulating a roadmap for prevention, innovative identification, and individualized therapeutic approaches.”
Title: The Lancet Commission on Sepsis: transforming sepsis care and outcomes
Authors: Manu Shankar-Hari, Damien Ming, Marc Mendelson, Priscilla Rupali, Neill K J Adhikari, Otavio Ranzani, Adrienne Randolph, Emma Davenport, Tom van der Poll, Luis Ferreira Moita, Abi Beane, Francois Lamontagne, Arthur Kwizera, Alison Holmes, Janet Diaz
Stay updated with Hemostasis Today.
-
Apr 24, 2026, 09:33Emmanuele Kouvousis: Do Calcium Supplements Increase the Risk of CVD Recurrence?
-
Apr 24, 2026, 09:19Stephen Bailey: Saving Lives Before Birth with Intrauterine Transfusions
-
Apr 24, 2026, 09:13Fatima Eltyeb Hago: Are We Doing More Harm Than Good with Combination Antithrombotic Therapy in AF?
-
Apr 24, 2026, 09:08Erica Sparkenbaugh: The Women Behind the UNC’s 12th Hemostasis Symposium
-
Apr 24, 2026, 09:07Michael Makris: When a Researcher Is Listed as First Author Without Knowing
-
Apr 24, 2026, 08:34Akmez Latona: Clauss vs PT-Derived Fibrinogen in Relation to Viscoelastic Clot Strength
-
Apr 24, 2026, 08:20Jack Shuang Hou: CorTec Wins FDA TAP Entry for Brain Interchange
-
Apr 24, 2026, 08:13Prasen Marella Highlights Recruitment Challenges in Stroke-Alzheimer’s Research at TS26 – UTHealth Houston Stroke
-
Apr 24, 2026, 08:03Shayla Kassam: Canadian Stroke Consortium’s Climate and Health Sustainability Policy is Officially Live Now